Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 6, 1997, Pages

  Clifford, S L ^a   Kaminetsky, C P ^a   Cirisano, F D ^a   Dodge, R ^a   Soper, J T ^a   Clarke Pearson, D L ^a   Berchuck, A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

p53 tumor suppressor gene; Race; Survival; Uterine cancer

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ADULT; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; EARLY CANCER; ENDOMETRIUM CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

EID: 0030843160     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70380-6     Document Type: Conference Paper

References (25)

1. BA Miller LAG Ries BF Hackney Cancer statistics review: 1973-1989 National Cancer Institute Publication No. (NIH) 92-2789 1992
2. CL Kosary FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin Surg Oncol 10 1994 31 46
3. LM Axtell MH Myers Contrasts in survival of black and white cancer patients, 1960-73 J Natl Cancer Inst 60 1978 1209 1215
4. JL Young Jr LG Ries ES Pollack Cancer patient survival among ethnic groups in the United States J Natl Cancer Inst 73 1984 341 352
5. J Howard BF Hankey RS Greenberg A collaborative study of differences in the survival rates of black patients and white patients with cancer Cancer 69 1992 2349 2360
6. A Berchuck J Boyd Molecular basis of endometrial cancer Cancer 76 1995 2034 2040
7. A Berchuck MF Kohler JR Marks The p53 tumor suppressor gene frequently is altered in gynecologic cancers Am J Obstet Gynecol 170 1994 246 252
8. MF Kohler A Berchuck AM Davidoff Overexpression and mutation of p53 in endometrial carcinoma Cancer Res 52 1992 1622 1627
9. AS Lukes MF Kohler CF Pieper Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer Cancer 73 1994 2380 2385
10. MF Kohler P Carney R Dodge A p53 overexpression in advanced-stage endometrial adenocarcinoma Am J Obstet Gynecol 175 1996 1246 1252
11. BJ Kerns PA Jordan MB Moore p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry J Histochem Cytochem 40 1992 1047 1051
12. MF Kohler BJ Kerns PA Humphrey Mutation and overexpression of p53 in early-stage epithelial ovarian cancer Obstet Gynecol 81 1993 643 650
13. P Armitage Statistical methods in medical research 1971 Blackwell Scientific Publications London 363 365
14. DW Hosmer S Lemeshow Applied logistic regression 1989 John Wiley & Sons New York 225 234
15. DR Cox Regression models and life tables J R Stat Soc B 34 1972 187 202
16. EL Kaplan P Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
17. N Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
18. M Inoue A Okayama M Fujita Clinicopathological characteristics of p53 overexpression in endometrial cancers Int J Cancer 58 1994 14 19
19. K Ito K Watanabe S Nasim Prognostic significance of p53 overexpression in endometrial cancer Cancer Res 54 1994 4667 4670
20. RP Bain RS Greenberg KC Chung Racial differences in survival of women with endometrial cancer Am J Obstet Gynecol 157 1987 914 923
21. SC Steinhorn MH Myers BF Hankey Factors associated with survival differences between black women and white women with cancer of the uterine corpus Am J Epidemiol 124 1986 85 93
22. HA Hill RJ Coates H Austin Racial differences in tumor grade among women with endometrial cancer Gynecol Oncol 56 1995 154 163
23. JR Liu M Conaway JT Soper Relationship between race and interval to treatment in endometrial cancer Obstet Gynecol 86 1995 486 490
24. J Schwartzbaum BS Hulka WC Fowler The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer Am J Epidemiol 126 1987 851 860
25. D Schottenfeld Determinants of black/white survival differences among women with endometrial cancer Gynecol Oncol 56 1995 151 153